{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:02:28Z","timestamp":1790668948510,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015990","name":"Sanofi K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030684","name":"Maruho","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.alit.2023.12.006","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T20:16:23Z","timestamp":1707768983000},"page":"323-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Topical application of activator protein-1 inhibitor T-5224 suppresses inflammation and improves skin barrier function in a murine atopic dermatitis-like dermatitis"],"prefix":"10.1016","volume":"73","author":[{"given":"Minori","family":"Sasakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Urakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Hasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Sunagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ennishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuta","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Morizane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2023.12.006_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaip.2019.06.044","article-title":"Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection","volume":"8","author":"Fishbein","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.alit.2023.12.006_bib2","article-title":"Review of prominent cytokines as superior therapeutic targets for moderate-to-severe atopic dermatitis","volume":"12","author":"Hassan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.alit.2023.12.006_bib3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.alit.2023.12.006_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.alit.2021.10.004","article-title":"Innovation in the treatment of atopic dermatitis: emerging topical and oral Janus kinase inhibitors","volume":"71","author":"Nakashima","year":"2022","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2023.12.006_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamadermatol.2019.0008","article-title":"Application of topical phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis: a systematic review and meta-analysis","volume":"155","author":"Yang","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.alit.2023.12.006_bib6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.jid.5700603","article-title":"Topical application with a new NF-kappaB inhibitor improves atopic dermatitis in NC\/NgaTnd mice","volume":"127","author":"Tanaka","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2023.12.006_bib7","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41598-022-05471-w","article-title":"Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment","volume":"12","author":"Eirefelt","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2023.12.006_bib8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar2338","article-title":"Activator protein 1 (Fos\/Jun) functions in inflammatory bone and skin disease","volume":"10","author":"Zenz","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.alit.2023.12.006_bib9","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1046\/j.1523-1747.2000.00149.x","article-title":"Dysregulated activation of activator protein 1 in keratinocytes of atopic dermatitis patients with enhanced expression of granulocyte\/macrophage-colony stimulating factor","volume":"115","author":"Pastore","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2023.12.006_bib10","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1021\/jm5004733","article-title":"Small molecule inhibitors targeting activator protein 1 (AP-1)","volume":"57","author":"Ye","year":"2014","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.alit.2023.12.006_bib11","first-page":"321","article-title":"FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice","volume":"283","author":"Nagai","year":"1997","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.alit.2023.12.006_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29410-w","article-title":"The role of metallothionein in a dinitrofluorobenzene-induced atopic dermatitis-like murine model","volume":"8","author":"Guo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2023.12.006_bib13","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/jid.2015.125","article-title":"Interferon-gamma enhances TLR3 expression and anti-viral activity in keratinocytes","volume":"135","author":"Kajita","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.alit.2023.12.006_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1158\/0008-5472.CAN-08-3125","article-title":"Cyclin-dependent kinase-3\u2013mediated c-jun phosphorylation at Ser63 and Ser73 enhances cell transformation","volume":"69","author":"Cho","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.alit.2023.12.006_bib15","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.3390\/ijms21155382","article-title":"Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17a, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2023.12.006_bib16","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10753-018-0740-8","article-title":"Involvement of the negative feedback of IL-33 signaling in the anti-inflammatory effect of electro-acupuncture on allergic contact dermatitis via targeting MicroRNA-155 in mast cells","volume":"41","author":"Wang","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.alit.2023.12.006_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1412","article-title":"Treatment of arthritis with a selective inhibitor of c-Fos\/activator protein-1","volume":"26","author":"Aikawa","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.alit.2023.12.006_bib18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2023.12.006_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.immuni.2011.02.012","article-title":"Functional specialization of interleukin-17 family members","volume":"34","author":"Iwakura","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2023.12.006_bib20","first-page":"217","article-title":"Activation of the AP-1 transcription factor by inflammatory cytokines of the TNF family","volume":"7","author":"Kyriakis","year":"1999","journal-title":"Gene Expr"},{"key":"10.1016\/j.alit.2023.12.006_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17289-y","article-title":"A\u00a0selective inhibition of c-Fos\/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain","volume":"7","author":"Makino","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2023.12.006_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12967-021-02932-0","article-title":"Inhibition of c-Fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1\/Egr1\/IL-4 axis","volume":"19","author":"Wang","year":"2021","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.alit.2023.12.006_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/cei.13575","article-title":"Keratinocytes: innate immune cells in atopic dermatitis","volume":"204","author":"Chieosilapatham","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.alit.2023.12.006_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5414\/ALX02272E","article-title":"Janus kinase inhibitors for the therapy of atopic dermatitis","volume":"5","author":"Traidl","year":"2021","journal-title":"Allergol Select"},{"key":"10.1016\/j.alit.2023.12.006_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/carcin\/bgs342","article-title":"Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity","volume":"34","author":"Kim","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.alit.2023.12.006_bib26","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2023.12.006_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.alit.2023.12.006_bib28","article-title":"Innate cells: the alternative source of IL-17 in axial and peripheral spondyloarthritis?","volume":"11","author":"Rosine","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2023.12.006_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/pr.119.018440","article-title":"Targeting Janus kinases and signal transducer and activator of transcription 3 to treat inflammation, fibrosis, and cancer: rationale, progress, and caution","volume":"72","author":"Bharadwaj","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.alit.2023.12.006_bib30","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1038\/s41598-019-41609-z","article-title":"Assessment and clinical relevance of serum IL-19 levels in psoriasis and atopic dermatitis using a sensitive and specific novel immunoassay","volume":"9","author":"Konrad","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.alit.2023.12.006_bib31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2340\/00015555-2723","article-title":"Increased interleukin-19 expression in cutaneous T-cell lymphoma and atopic dermatitis","volume":"97","author":"Oka","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.alit.2023.12.006_bib32","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.4049\/jimmunol.1600126","article-title":"Expression of IL-22 in the skin causes Th2-biased immunity, epidermal barrier dysfunction, and pruritus via stimulating epithelial Th2 cytokines and the GRP pathway","volume":"198","author":"Lou","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.alit.2023.12.006_bib33","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/eji.201041197","article-title":"IL-22 and TNF-alpha represent a key cytokine combination for epidermal integrity during infection with Candida albicans","volume":"41","author":"Eyerich","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.alit.2023.12.006_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2019.08.006","article-title":"Interleukin-33 in atopic dermatitis","volume":"96","author":"Imai","year":"2019","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.alit.2023.12.006_bib35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 Axis in immune cells during inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.alit.2023.12.006_bib36","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.3390\/ijms19103086","article-title":"New cytokines in the pathogenesis of atopic dermatitis-new therapeutic targets","volume":"19","author":"Klonowska","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.alit.2023.12.006_bib37","first-page":"2476","article-title":"Effect of S100A8 and S100A9 on expressions of cytokine and skin barrier protein in human keratinocytes","volume":"20","author":"Kim","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.alit.2023.12.006_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.12.006_bib39","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.jaci.2020.02.008","article-title":"Reconciling innate and acquired immunity in atopic dermatitis","volume":"145","author":"Honda","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.alit.2023.12.006_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4168\/aair.2018.10.3.207","article-title":"Significance of skin barrier dysfunction in atopic dermatitis","volume":"10","author":"Kim","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.alit.2023.12.006_bib41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1600-0625.2012.01472.x","article-title":"The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family","volume":"21","author":"Kypriotou","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.alit.2023.12.006_bib42","article-title":"Urban particulate matter down-regulates filaggrin via COX2 expression\/PGE2 production leading to skin barrier dysfunction","volume":"6","author":"Lee","year":"2016","journal-title":"Sci Rep"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893023001417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893023001417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T04:25:53Z","timestamp":1711772753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893023001417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1323893023001417"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2023.12.006","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical application of activator protein-1 inhibitor T-5224 suppresses inflammation and improves skin barrier function in a murine atopic dermatitis-like dermatitis","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2023.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Allergology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}